Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.87B | 11.35B | 10.93B | 9.61B | 10.64B | 10.59B | Gross Profit |
3.05B | 3.00B | 2.87B | 2.47B | 2.62B | 2.48B | EBIT |
1.06B | 867.07M | 852.01M | 573.19M | 763.64M | 721.59M | EBITDA |
1.48B | 1.35B | 1.36B | 1.01B | 1.28B | 1.03B | Net Income Common Stockholders |
684.67M | 654.72M | 580.07M | 336.16M | 521.35M | 393.72M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.85B | 2.78B | 2.74B | 2.40B | 2.64B | 1.96B | Total Assets |
9.20B | 9.75B | 9.24B | 8.24B | 8.71B | 9.45B | Total Debt |
150.00M | 421.00M | 213.80M | 332.15M | 460.27M | 516.36M | Net Debt |
-2.70B | -2.36B | -2.53B | -1.64B | -1.74B | -972.55M | Total Liabilities |
2.75B | 3.07B | 3.06B | 2.56B | 3.14B | 4.13B | Stockholders Equity |
6.45B | 6.68B | 6.19B | 5.67B | 5.57B | 5.32B |
Cash Flow | Free Cash Flow | ||||
0.00 | 484.42M | 1.15B | 160.67M | 1.19B | -52.51M | Operating Cash Flow |
0.00 | 663.15M | 1.30B | 487.44M | 1.70B | 419.90M | Investing Cash Flow |
0.00 | -254.16M | -157.31M | -327.14M | -507.51M | -474.12M | Financing Cash Flow |
0.00 | -368.65M | -371.16M | -396.78M | -480.69M | -358.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥7.03B | 10.73 | 2.82% | 3.93% | 12.87% | ||
77 Outperform | ¥6.62B | 10.59 | 1.60% | 12.97% | 25.37% | ||
76 Outperform | ¥7.15B | 9.61 | 3.56% | 5.00% | 10.16% | ||
75 Outperform | ¥6.73B | 28.97 | ― | 12.37% | -27.25% | ||
73 Outperform | ¥7.35B | 7.17 | 3.50% | 3.61% | -14.09% | ||
69 Neutral | ¥6.63B | 11.96 | 4.89% | 13.09% | 61.54% | ||
62 Neutral | $11.80B | 10.10 | -7.47% | 2.99% | 7.37% | -8.16% |